Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain D2-Like Dopamine Receptor Distribution in Rats with Different Types of Genetic Epilepsy.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2023
Same author

[The Role of Blood-Brain Barrier in the Development of Childhood Febrile Seizures and Temporal Lobe Epilepsy.]

Fiziologiia cheloveka·2018
Same author

Structural alterations in the rat brain and behavioral impairment after status epilepticus: An MRI study.

Neuroscience·2015
Same author

The use of automated system for EEG analysis and feedback cerebral stimulation to stop epileptiform activity in WAG/Rij rats.

Bulletin of experimental biology and medicine·2015
Same author

[Evaluation of a long-term sensomotor deficit after neonatal rat brain ischemia/hypoxia].

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova·2014
Same author

[A perspective of present approaches to EEG analyses performed with intention to find seizure predictors].

Uspekhi fiziologicheskikh nauk·2011
Same journal

Sensitivity of T-Lymphocytes to Hormones of the Anterior Pituitary Gland.

Uspekhi fiziologicheskikh nauk·2017
Same journal

Digestive and Nondigestive Functions of Rodents' Salivary Glands.

Uspekhi fiziologicheskikh nauk·2017
Same journal

Diabetes, from the Origins of the Problem to the Nobel Prize. Bioethics.

Uspekhi fiziologicheskikh nauk·2017
Same journal

Molecular Mechanisms of Action of Gas Transmitters NO, CO and H2S in Smooth Muscle Cells and Effect of NO-generating Compounds (Nitrates and Nitrites) on Average Life Expectancy.

Uspekhi fiziologicheskikh nauk·2017
Same journal

Memory, Cognition and the Endogenous Evoked Potentials of the Brain: the Estimation of the Disturbance of Cognitive Functions and Capacity of Working Memory Without the Psychological Testing.

Uspekhi fiziologicheskikh nauk·2017
Same journal

The JAM Family of Molecules and Their Role in the Regulation of Physiological and Pathological Processes.

Uspekhi fiziologicheskikh nauk·2017
See all related articles

Related Experiment Video

Updated: May 21, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

[Neuroprotection in epilepsy].

S A Chepurnov, E M Suleĭmanova, M V Guliaev

    Uspekhi Fiziologicheskikh Nauk
    |June 14, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Traumatic brain injuries and prolonged seizures cause brain damage, leading to cognitive deficits and epilepsy. Current anticonvulsant drugs lack sufficient neuroprotective effects, necessitating research into novel therapies.

    More Related Videos

    Pentylenetetrazole-Induced Kindling Mouse Model
    07:06

    Pentylenetetrazole-Induced Kindling Mouse Model

    Published on: June 12, 2018

    Lipidomics and Transcriptomics in Neurological Diseases
    09:58

    Lipidomics and Transcriptomics in Neurological Diseases

    Published on: March 18, 2022

    Related Experiment Videos

    Last Updated: May 21, 2026

    Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
    07:01

    Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    Pentylenetetrazole-Induced Kindling Mouse Model
    07:06

    Pentylenetetrazole-Induced Kindling Mouse Model

    Published on: June 12, 2018

    Lipidomics and Transcriptomics in Neurological Diseases
    09:58

    Lipidomics and Transcriptomics in Neurological Diseases

    Published on: March 18, 2022

    Area of Science:

    • Neuroscience
    • Neurology
    • Pharmacology

    Background:

    • Traumatic brain injury, ischemic stroke, and status epilepticus cause neuronal loss and long-term consequences.
    • These conditions can lead to impaired learning, memory, cognitive functions, and chronic epilepsy, particularly temporal lobe epilepsy.
    • Epilepsy patients face an elevated risk of status epilepticus, a critical condition involving prolonged seizures.

    Purpose of the Study:

    • To investigate the potential of neuroprotective drugs in preventing brain damage and neuronal loss associated with prolonged seizures.
    • To evaluate the efficacy of existing anticonvulsant drugs in mitigating the pathological processes of status epilepticus.
    • To identify promising avenues for developing effective neuroprotective strategies against seizure-induced brain injury.

    Main Methods:

    • Review of existing literature on neuroprotection and anticonvulsant drug efficacy.
    • Analysis of studies examining the effects of classic and novel anticonvulsant drugs on neuroprotection.
    • Exploration of pathological processes including neuronal apoptosis and necrosis in the context of prolonged seizures.

    Main Results:

    • Current anticonvulsant drugs demonstrate insufficient neuroprotective effects.
    • These drugs are largely ineffective in preventing epileptogenesis.
    • Existing treatments do not adequately prevent brain damage resulting from prolonged seizures.

    Conclusions:

    • There is a critical need for novel neuroprotective drugs to manage brain damage from prolonged seizures.
    • Further research into alternative neuroprotective agents is essential.
    • Effective prevention of seizure-induced brain damage remains an unmet clinical challenge.